1. Home
  2. ACDC vs CGEM Comparison

ACDC vs CGEM Comparison

Compare ACDC & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProFrac Holding Corp.

ACDC

ProFrac Holding Corp.

N/A

Current Price

$3.92

Market Cap

640.3M

Sector

Energy

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$9.58

Market Cap

671.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACDC
CGEM
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
671.7M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ACDC
CGEM
Price
$3.92
$9.58
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$5.83
$28.00
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,960,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$5.68
52 Week High
$10.70
$13.33

Technical Indicators

Market Signals
Indicator
ACDC
CGEM
Relative Strength Index (RSI) 46.95 44.82
Support Level $3.78 $10.01
Resistance Level $4.64 $13.10
Average True Range (ATR) 0.30 1.00
MACD 0.02 -0.27
Stochastic Oscillator 44.79 3.73

Price Performance

Historical Comparison
ACDC
CGEM

About ACDC ProFrac Holding Corp.

ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: